Adverum Biotechnologies
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $0 | $0 | $-3,600 |
Gross Profit | 110 | -956 | -997 | -4,608 |
EBITDA | -26,244 | -17,520 | -27,142 | -26,126 |
EBIT | -27,134 | -18,476 | -28,139 | -27,134 |
Net Income | -27,134 | -18,476 | -24,787 | -23,714 |
Net Change In Cash | 1,000 | 0 | 0 | -3,600 |
Free Cash Flow | -21,345 | -19,860 | -23,335 | -21,596 |
Cash | 92,851 | 127,321 | 149,608 | 75,000 |
Basic Shares | 20,876 | 20,852 | 16,479 | 10,121 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,600 | $3,600 | $7,500 | $7,500 |
Gross Profit | -2,044 | -6,528 | 2,855 | -4,158 |
EBITDA | -112,599 | -147,934 | -140,895 | -112,235 |
EBIT | -118,243 | -154,462 | -145,540 | -116,393 |
Net Income | -117,165 | -154,536 | -145,540 | -117,507 |
Net Change In Cash | 3,600 | 3,600 | 7,500 | 7,500 |
Cost of Revenue | -26,725 | -3,473 | ||
Free Cash Flow | -91,710 | -119,907 | -122,954 | -91,135 |
Cash | 75,000 | 68,431 | 34,195 | 62,424 |
Basic Shares | 10,082 | 9,925 | 9,803 | 8,514 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.30 |
2024-06-30 | -$0.89 |
2024-03-31 | -$1.50 |
2023-12-31 | -$2.30 |
